UK medical cannabis registry: assessment of clinical outcomes in patients with headache disorders.

Expert review of neurotherapeutics(2023)

引用 1|浏览15
暂无评分
摘要
Improvements in headache/migraine-specific PROMs and general health-related quality of life were associated with the initiation of CBMPs in patients with headache disorders. Cautious interpretation of results is necessary, and randomized control trials are required to ascertain causality.
更多
查看译文
关键词
Medical cannabis,cannabidiol,headache,migraine,tetrahydrocannabinol
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要